A Phase L Study of a Tumor-Targeted Systemic Nanodelivery System, SGT-94, in Genitourinary Cancers
Molecular Therapy - United States
doi 10.1038/mt.2016.118
Full Text
Open PDFAbstract
Available in full text
Date
August 1, 2016
Authors
Publisher
Elsevier BV